跳至主要内容
临床试验/CTRI/2025/02/080808
CTRI/2025/02/080808尚未招募2 期

Randomized controlled clinical study to evaluate the efficacy of vruddhadaru churna in treatment of generalized anxiety disorder in geriatric age group.

Dr Pallavi Gajanan Chincholkar1 个研究点 分布在 1 个国家目标入组 50 人开始时间: 2025年2月25日最近更新:

试验速览

阶段
2 期
状态
尚未招募
发起方
入组人数
50
试验地点
1
主要终点
reduction in symptoms of generalised anxiety disorder

研究概览

简要总结

Present study is based on understanding the effect of Vruddhadaru churna in Generalised Anxiety Disorder in geraiatic patients suffering from fatigue, mental confusion, sleep disturbances, restlessness, lower level of cognitive and somatic distress and panic disorders. current study will include 50 patients which will be divided into two groups for better understanding. study will be of 45 days with 30 days of intervention with 1gm of Vruddhadaru churna with jala in patients of Group A. Group B will be treated with conventional Protocol of Anxiety. Folllowup will be taken after 15 days of intervention. It is expected to have reduction in the above mentioned symptoms with the 30 days intervention

研究设计

研究类型
Interventional
分配方式
Other
盲法
None

入排标准

年龄范围
60.00 Year(s) 至 80.00 Year(s)(—)
性别
All

入选标准

  • patients suffering from symptoms of genralized anxiety disorder such as fatigue, mental confusion , worry, sleep disturbances, restlessness lower level of cognitive ad somatic distress, panic disorder, more dizziness and faintness.

排除标准

  • Serious illness such as cancer kidney disease and heart disease known case of mental retardation or having any other psychological disorders.

结局指标

主要结局

reduction in symptoms of generalised anxiety disorder

时间窗: 45 days

次要结局

  • increase quality of life(sound sleep)

研究者

发起方
Dr Pallavi Gajanan Chincholkar
申办方类型
Other [self]
责任方
Principal Investigator
主要研究者

Dr Pallavi Gajanan Chincholkar

Tilak Ayurved Mahavidyalaya, Pune

研究点 (1)

Loading locations...

相似试验